Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-033219
Filing Date
2019-05-29
Accepted
2019-05-29 16:52:12
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 6557
  Complete submission text file 0001209191-19-033219.txt   7973
Mailing Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173
Business Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173 212-220-9319
Applied Therapeutics Inc. (Issuer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Shendelman Shoshana (Reporting) CIK: 0001775490 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38898 | Film No.: 19862684